Reproductive and menstrual factors and risk of ductal carcinoma in situ of the breast in a cohort of postmenopausal women

Cancer Causes and Control

Volumn 22, Issue 10, 2011, Pages 1415-1424

  Kabat, Geoffrey C ^a   Kim, Mimi Y ^a   Woods, Nancy F ^b   Habel, Laurel A ^c   Messina, Catherine R ^d   Wactawski Wende, Jean ^e   Stefanick, Marcia L ^f   Chlebowski, Rowan ^g   Wassertheil Smoller, Sylvia ^a   Rohan, Thomas E ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c DIVISION OF RESEARCH   (United States)

^d STONY BROOK UNIVERSITY   (United States)

^e UNIVERSITY AT BUFFALO   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Ductal carcinoma in situ (DCIS); Grade; Hormone therapy; Mammographic screening; Menstrual factors; Natural history; Reproductive factors

Indexed keywords

ADULT; AGE; ARTICLE; BODY MASS; BREAST FEEDING; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; FOLLOW UP; HORMONAL THERAPY; HUMAN; INTRADUCTAL CARCINOMA; LIVE BIRTH; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MENARCHE; MENOPAUSE; MENSTRUATION; PARITY; POSTMENOPAUSE; PRIORITY JOURNAL; REPRODUCTIVE HEALTH;

BREAST FEEDING; BREAST NEOPLASMS; CARCINOMA, DUCTAL; CLINICAL TRIALS AS TOPIC; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MENARCHE; MENOPAUSE; MENSTRUATION; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; POSTMENOPAUSE; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCTIVE HISTORY; RISK FACTORS; WOMEN'S HEALTH;

EID: 82955232879     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-011-9814-8     Document Type: Article

References (37)

1. Harris JR, Lippman ME, Veronesi U, Willett WC (1992) Breast cancer (1). N Engl J Med 327:319-328
2. Kelsey JL, Gammon MD, John EM (1993) Reproductive factors and breast cancer. Epidemiol Rev 15:36-47 (Pubitemid 23269069)
3. Key TJ, Verkasalo PK, Bank E (2001) Epidemiology of breastcancer. Lancet Oncol 2:133-140
4. Colditz GA, Baer HJ, Tamimi RM Breast cancer. In: Schottenfeld D, Fraumeni JF Jr. (eds) Cancer epidemiology and prevention (3rd edition), New York: Oxford University Press, 2006, pp 995-1012
5. Pike MC, Spicer DV, Dahmoush L, Press MF (1993) Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 15:17-35 (Pubitemid 23269068)
6. Hankinson SE, Colditz GA, Willett WC (2004) Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Res 6:213-218. doi:10.1186/bcr921 (Pubitemid 39220377)
7. Weiss HA, Brinton LA, Brogan D, Coates RJ, Gammon MD, Malone KE, Schoenberg JB (1996) Epidemiology of in situ and invasive breast cancer in women aged under 45. Br J Cancer 73:1298-1305 (Pubitemid 26162350)
8. Longnecker MP, Bernstein L, Paganini-Hill A, Enger SM, Ross RK (1996) Risk factors for in situ breast cancer. Cancer Epidemiol Biomarkers Prev 5:961-965 (Pubitemid 26415867)
9. Kerlikowske K, Barclay J, Grady D, Sickles EA, Ernster V (1997) Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer. J Natl Cancer Inst 89:76-82
10. Lambe M, Hsieh C-C, Tsaih S-W, Ekbom A, Trichopoulos D, Adami H-O (1998) Parity, age at first birth and the risk of carcinoma in situ of the breast. Int J Cancer 77:330-332 (Pubitemid 28299864)
11. Trentham-Dietz A, Newcomb PA, Storer BE, Remington PL (2000) Risk factors for carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev 9:697-703 (Pubitemid 30482701)
12. Claus EB, Stowe M, Carter D (2001) Breast carcinoma in situ: risk factors and screening patterns. J Natl Cancer Inst 93:1811-1817 (Pubitemid 33150454)
13. Wohlfahrt J, Rank F, Kroman N, Melbye M (2004) A comparison of reproductive risk factors for CIS lesions and invasive breast cnacer. Int J Cancer 108:750-753 (Pubitemid 38076407)
14. Granström C, Sundquist J, Hemminki K (2008) Population attributable risks for breast cancer in Swedish women by morphological type. Breast Cancer Res Treat 111:559-568
15. Phillips LS, Millikan RC, Schroeder JC, Barnholtz-Sloan JS, Levine BJ (2009) Reproductive and hormonal risk factors for ductal carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev 18:1507-1514
16. Ma J, Henderson KD, Sullivan-Halley J, Duan L, Marshall SF, Ursin G, Horn-Ross P, Largent J, Deapen DM, Lacey JV, Bernstein L (2010) Breast Cancer Res 12:R35 http//:breast-cancer- research.com/content/12/3/R35
17. Allegra CJ, Aberle DR, Ganschow P et al (2010) National institutes of health state-of-the-science conference statement: diagnosis and management of ductal carcinoma in situ september 22-24, 2009. J Natl Cancer Inst 102(3):161-169
18. Virnig BA, Tuttle TM, Shamlilyan T, Kane RL (2010) Ductal carcinoma in situ of the breast: a systemic review of incidence, treatment, and outcomes. J Natl Cancer Inst 102(3):170-178
19. Shackney SE, Silverman JF (2003) Molecular evolutionary patterns of breast cancer. Adv Anat Pathol 10:278-290
20. Erbas B, Provenzano E, Armes J, Gertig D (2006) The naturalhistory of ductal carcinoma in situ of the breast: a review. Breast Cancer Res Treat 97:135-144
21. Anderson WF, Chu KC, Devesa SS (2004) Distinct incidence patterns among in situ and invasive breast carcinomas, with possible etiologic implications. Breast Cancer Res Treat 88:149-159 (Pubitemid 39575572)
22. The women's health initiative study group (1998) Design of the women's health initiative clinical trial and observational study. Control Clin Trials 19:61-109
23. Anderson GL, Manson J, Wallace R et al (2003) Implementation of the women's health initiative study design. Ann Epidemiol 13:S5-S17 (Pubitemid 37324175)
24. Langer RD, White E, Lewis CE, Kotchen JM, Hendrix SL, Trevisan M (2003) The women's health initiative observational study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol 13:S107-S121 (Pubitemid 37324180)
25. Curb JD, McTiernan A, Heckbert SR et al (2003) Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann Epidemiol (9 Suppl): S122-S128 (Pubitemid 37324181)
26. Chlebowski RT, Hendrix SL, Langer RD et al (2003) Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the women's health initiative randomized trial. JAMA 289:3243-3253 (Pubitemid 37430077)
27. Prentice RL, Caan B, Chlebowski RT et al (2006) Low-fat dietary pattern and risk of invasive breast cancer: the women's health initiative randomized controlled dietary modification trial. JAMA 295:629-642 (Pubitemid 43209065)
28. Kerlikowske K (2010) Epidemiology of ductal carcinoma in situ. J Natl Cancer Inst Monogr 41:139-141
29. Kuerer HM, Albarracin CT, Yang WT et al (2008) Ductal carcinoma in situ: state of the science and roadmap to advance the field. J Clin Oncol 27:279-288
30. Sontag L, Axelrod DE (2005) Evaluation of pathways for progression of heterogeneous breast tumors. J Theor Biol 232:179-189 (Pubitemid 39458046)
31. Dupont WD, Parl FF, Hartmann WH et al (1993) Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 71:1258-1265 (Pubitemid 23054916)
32. Carter CL, Corle DK, Micozzi MS, Schatzkin A, Taylor PR (1988) A prospective study of the development of breast cancer in 16, 692 women with benign breast disease. Am J Epidemiol 128:467-477
33. Lakhani SR, Chaggar R, Davies S et al (1999) Genetic alterations in 'normal' luminal and myoepithelial cells of the breast. J Pathol 189:496-503
34. Kinne DW, Petrek JA, Osborne MP, Fracchia AA, DePaol AA, Rosen PP (1989) Breast carcinoma in situ. Arch Surg 124:33-36 (Pubitemid 19025899)
35. Morrow M, Schnitt SJ, Harris JR (2000) Ductal carcinoma in situ and microinvasive carcinoma. In: Harris JR, Lippman ME, Morrow M, Osborne CK (eds) Diseases of the breast. Lippincott Williams & Wilkins, Philadelphia, pp 383-401
36. Morrow M (1992) Precancerous breast lesions: implications for breast cancer prevention trials. Int J Oncol 23:1071-1078
37. Anderson GL, Limacher M, Assaf AR et al (2004) Effects of equine estrogen in postmenopausal women with hypterectomy: the women's health initiative randomized controlled trial. JAMA 291:1701-1712 (Pubitemid 38489892)